Steatohepatitis/Metabolic Liver Disease
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study†
Article first published online: 12 FEB 2010
Copyright © 2010 American Association for the Study of Liver Diseases
Volume 51, Issue 6, pages 1979–1987, June 2010
How to Cite
Speliotes, E. K., Massaro, J. M., Hoffmann, U., Vasan, R. S., Meigs, J. B., Sahani, D. V., Hirschhorn, J. N., O'Donnell, C. J. and Fox, C. S. (2010), Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study. Hepatology, 51: 1979–1987. doi: 10.1002/hep.23593
Potential conflict of interest: D. V. S. has a research agreement with General Electric and is on the Speakers' Bureau of Bracco Diagnostics. J. B. M. currently has research grants from GlaxoSmithKline and sanofi-aventis, and has consulting agreements with Eli Lilly and Interleukin Genetics. Dr. Hirshhorn advises Correlagen Diagnostics, Inc.
- Issue published online: 23 MAY 2010
- Article first published online: 12 FEB 2010
- Accepted manuscript online: 12 FEB 2010 12:00AM EST
- Manuscript Accepted: 13 JAN 2010
- Manuscript Received: 20 JUL 2009
- National Institutes of Health. Grant Number: T32 DK07191-32
- Department of Gastroenterology at Massachusetts General Hospital. Grant Numbers: F32 DK079466-01, K23 DK080145-01
- Framingham Heart Study. Grant Number: N01-HC25195
- American Diabetes Association Career Development Award
- General Clinical Research Centers Program. Grant Number: M01-RR-01066
- National Institute of Diabetes and Digestive and Kidney Diseases. Grant Number: K24 DK080140
Additional Supporting Information may be found in the online version of this article.
|HEP_23593_sm_suppfig1.tif||418K||Supporting Fig 1.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.